Eudaimonia Asset Management »

Monte Rosa Therapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 70k 15.68

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics